A drug candidate developed by Salk researchers, and previously shown to slow aging in brain cells, successfully reversed memory loss in a mouse model of inherited Alzheimer’s disease. The new research, published online in July 2020 in the journal Redox Biology, also revealed that the drug, CMS121, works by changing how brain cells metabolize fatty molecules known as lipids.
- Integrated anemia-SCD test demonstrates accurate results in study at 2020 ASH meeting
- Study reveals surprising benefit of clonal hematopoiesis in allogeneic transplants
- Researchers adapt cell phone camera for SARS-CoV-2 detection
- Mailman School experts contribute to new Lancet report on health and climate change
- Research reveals how airflow inside a car may affect COVID-19 transmission risk